Grossberg AJ, Chu LC, Deig CR, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70:375–403.
Article PubMed PubMed Central Google Scholar
Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795-806.e12.
Article PubMed PubMed Central CAS Google Scholar
de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403.
Pfeifer E, Burchell JM, Dazzi F, et al. Apoptosis in the pancreatic cancer tumor microenvironment-the double-edged sword of cancer-associated fibroblasts. Cells. 2021;10:1653–70.
Article PubMed PubMed Central CAS Google Scholar
Hessmann E, Buchholz SM, Demir IE, et al. Microenvironmental determinants of pancreatic cancer. Physiol Rev. 2020;100:1707–51.
Seton-Rogers S. Fibroblasts shape PDAC architecture. Nat Rev Cancer. 2019;19:418.
Article PubMed CAS Google Scholar
Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2022;22:131–42.
Article PubMed CAS Google Scholar
Atkinson MA, Campbell-Thompson M, Kusmartseva I, et al. Organisation of the human pancreas in health and in diabetes. Diabetologia. 2020;63:1966–73.
Article PubMed PubMed Central Google Scholar
Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008;134:981–7.
Article PubMed CAS Google Scholar
Aggarwal G, Kamada P, Chari ST. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas. 2013;42:198–201.
Article PubMed PubMed Central Google Scholar
2. Diagnosis and Classification of Diabetes. Standards of Care in Diabetes-2024. Diabetes Care. 2024;47:S20-42.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care. 2003;26(Suppl 1):S5-20.
Ewald N, Kaufmann C, Raspe A, et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338–42.
Article PubMed CAS Google Scholar
Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(3573–87): e29.
Do VH, Canzar S. A generalization of t-SNE and UMAP to single-cell multimodal omics. Genome Biol. 2021;22:130–8.
Article PubMed PubMed Central Google Scholar
Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088–107.
Article PubMed PubMed Central CAS Google Scholar
Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.
Article PubMed PubMed Central CAS Google Scholar
Wigger L, Barovic M, Brunner AD, et al. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes. Nat Metab. 2021;3:1017–31.
Article PubMed CAS Google Scholar
Kamarajah SK, Burns WR, Frankel TL, et al. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging system for patients with pancreatic adenocarcinoma: a surveillance, epidemiology and end results (SEER) analysis. Ann Surg Oncol. 2017;24:2023–30.
Kasurinen J, Hagström J, Kaprio T, et al. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: the additional prognostic value of CD8+-to-CD3+ ratio remains debatable. Tumour Biol. 2022;44:37–52.
Ackermann Misfeldt A, Costa RH, Gannon M. Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1. Diabetes. 2008;57:3069–77.
Article PubMed PubMed Central Google Scholar
Kao KC, Vilbois S, Tsai CH, et al. Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022;24:1574–83.
Article PubMed CAS Google Scholar
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–37.
Article PubMed PubMed Central CAS Google Scholar
Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74–80.
Article PubMed CAS Google Scholar
Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–22.
Article PubMed CAS Google Scholar
Rebelo R, Xavier CPR, Giovannetti E, et al. Fibroblasts in pancreatic cancer: molecular and clinical perspectives. Trends Mol Med. 2023;29:439–53.
Article PubMed CAS Google Scholar
Caronni N, la Terza F, Vittoria FM, et al. IL-1β (+) macrophages fuel pathogenic inflammation in pancreatic cancer. Nature. 2023;623:415–22.
Article PubMed CAS Google Scholar
Wang Y, Ni Q, Sun J, et al. Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer. J Clin Endocrinol Metab. 2020;105:dgz224.
Javeed N, Sagar G, Dutta SK, et al. Pancreatic cancer-derived exosomes cause paraneoplastic β-cell dysfunction. Clin Cancer Res. 2015;21:1722–33.
Article PubMed CAS Google Scholar
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.
Liao WC, Tu YK, Wu MS, et al. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ. 2015;350:g7371–82.
Article PubMed PubMed Central Google Scholar
Quoc Lam B, Shrivastava SK, Shrivastava A, et al. The Impact of obesity and diabetes mellitus on pancreatic cancer: molecular mechanisms and clinical perspectives. J Cell Mol Med. 2020;24:7706–16.
Article PubMed PubMed Central CAS Google Scholar
Pizzato M, Turati F, Rosato V, et al. Exploring the link between diabetes and pancreatic cancer. Expert Rev Anticancer Ther. 2019;19:681–7.
Article PubMed CAS Google Scholar
Hart PA, Bellin MD, Andersen DK, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroent
Comments (0)